Reuters NewMedia - January 10, 2012
Health regulators said they have received applications from
generic drugmakers to make copycat versions of Merck & Co's HIV
drug Isentress, GlaxoSmithKline's HIV drug Epivir and Bayer AG's
birth control pill Beyaz.
However, the U.S. Food and Drug Administration did not disclose
the names of the generic drug applicants.
Isentress was first approved in 2007 for use in adult patients.
Last month, the FDA expanded the label on the drug for use in
children and adolescents.
Merck shares were trading almost flat at $38.58 on Tuesday on the
New York Stock Exchange.
(Reporting by Anand Basu in Bangalore; Editing by Supriya Kurane)